Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint 0 10.05.2024 23:55 The Wall Street Journal Bristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
